These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 36333751)

  • 1. Effect of early stellate ganglion block in cerebral vasospasm after aneurysmal subarachnoid hemorrhage (BLOCK-CVS): study protocol for a randomized controlled trial.
    Jing L; Wu Y; Liang F; Jian M; Bai Y; Wang Y; Liu H; Wang A; Chen X; Han R
    Trials; 2022 Nov; 23(1):922. PubMed ID: 36333751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early stellate ganglion block for improvement of postoperative cerebral blood flow velocity after aneurysmal subarachnoid hemorrhage: results of a pilot randomized controlled trial.
    Wu Y; Lin F; Bai Y; Liang F; Wang X; Wang B; Jian M; Wang Y; Liu H; Wang A; Chen X; Han R
    J Neurosurg; 2023 Nov; 139(5):1339-1347. PubMed ID: 37119094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stellate Ganglion Block and Intraarterial Spasmolysis in Patients with Cerebral Vasospasm: A Retrospective Cohort Study.
    Wendel C; Oberhauser C; Schiff J; Henkes H; Ganslandt O
    Neurocrit Care; 2024 Apr; 40(2):603-611. PubMed ID: 37498456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stellate ganglion block combined with intra-arterial treatment: a "one-stop shop" for cerebral vasospasm after aneurysmal subarachnoid hemorrhage-a pilot study.
    Pileggi M; Mosimann PJ; Isalberti M; Piechowiak EI; Merlani P; Reinert M; Cianfoni A
    Neuroradiology; 2021 Oct; 63(10):1701-1708. PubMed ID: 33725155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Hydrogen-Oxygen Gas Mixture Inhalation in Patients with Aneurysmal Subarachnoid Hemorrhage (HOMA): study protocol for a randomized controlled trial.
    Lin F; Li R; Chen Y; Yang J; Wang K; Jia Y; Han H; Hao Q; Shi G; Wang S; Zhao Y; Chen X
    Trials; 2024 Jun; 25(1):377. PubMed ID: 38863026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiographic Treatment of Asymptomatic Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage for the Prevention of Delayed Cerebral Ischemia.
    Rebeiz T; Sabirov T; Wanchoo S; White TG; Da Silva I; Stefanov DG; Temes RE
    World Neurosurg; 2022 Oct; 166():e135-e139. PubMed ID: 35787959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The REACT study: design of a randomized phase 3 trial to assess the efficacy and safety of clazosentan for preventing deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Bruder N; Higashida R; Santin-Janin H; Dubois C; Aldrich EF; Marr A; Roux S; Mayer SA
    BMC Neurol; 2022 Dec; 22(1):492. PubMed ID: 36539711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Cilostazol in Prevention of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.
    Saber H; Desai A; Palla M; Mohamed W; Seraji-Bozorgzad N; Ibrahim M
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):2979-2985. PubMed ID: 30093204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients.
    Endo H; Hagihara Y; Kimura N; Takizawa K; Niizuma K; Togo O; Tominaga T
    J Neurosurg; 2022 Dec; 137(6):1707-1717. PubMed ID: 35364589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of stellate ganglion block on delayed cerebral vasospasm in an experimental rat model of subarachnoid hemorrhage.
    Hu N; Wu Y; Chen BZ; Han JF; Zhou MT
    Brain Res; 2014 Oct; 1585():63-71. PubMed ID: 25128600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stellate Ganglion Block in Subarachnoid Hemorrhage: A Promising Protective Measure Against Vasospasm?
    Oliveira LB; Batista S; Prestes MZ; Bocanegra-Becerra JE; Rabelo NN; Bertani R; Welling LC; Figueiredo EG
    World Neurosurg; 2024 Feb; 182():124-131. PubMed ID: 38042290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Stellate Ganglion Block in the Management of Cerebral Vasospasm: A Prospective Interventional Study.
    Samagh N; Panda NB; Gupta V; Bharti N; Tripathi M; Bhagat H; Chhabra RK; Jangra K; Luthra A
    Neurol India; 2022; 70(1):289-295. PubMed ID: 35263898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Statins in Cerebral Vasospasm, Mortality, and Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Shen J; Shen J; Zhu K; Zhou H; Tian H; Yu G
    World Neurosurg; 2019 Nov; 131():e65-e73. PubMed ID: 31295598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical impact and safety profile of high-dose intra-arterial verapamil treatment for cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
    Mao G; Gigliotti MJ; Esplin N; Sexton K
    Clin Neurol Neurosurg; 2021 Mar; 202():106546. PubMed ID: 33588359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical Ganglion Sympathectomy to Treat Cerebral Vasospasm in Subarachnoid Hemorrhage.
    Salvagno M; Gouvea Bogossian E; Halenarova K; Ego A; Taccone FS
    Neurocrit Care; 2023 Aug; 39(1):241-249. PubMed ID: 36828982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive Effect of Clazosentan against Cerebral Vasospasm after Clipping Surgery for Aneurysmal Subarachnoid Hemorrhage in Japanese and Korean Patients.
    Fujimura M; Joo JY; Kim JS; Hatta M; Yokoyama Y; Tominaga T
    Cerebrovasc Dis; 2017; 44(1-2):59-67. PubMed ID: 28463833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fight INflammation to Improve outcome after aneurysmal Subarachnoid HEmorRhage (FINISHER) trial: Study protocol for a randomized controlled trial.
    Güresir E; Lampmann T; Bele S; Czabanka M; Czorlich P; Gempt J; Goldbrunner R; Hurth H; Hermann E; Jabbarli R; Krauthausen M; König R; Lindner D; Malinova V; Meixensberger J; Mielke D; Németh R; Darkwah Oppong M; Pala A; Prinz V; Rashidi A; Roder C; Sandalcioglu IE; Sauvigny T; Schebesch KM; Timmer M; Vajkoczy P; Wessels L; Wild F; Wilhelm C; Wostrack M; Vatter H; Coch C
    Int J Stroke; 2023 Feb; 18(2):242-247. PubMed ID: 35361026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of statin treatment on vasospasm-related morbidity and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
    Shen J; Huang KY; Zhu Y; Pan JW; Jiang H; Weng YX; Zhan RY
    J Neurosurg; 2017 Aug; 127(2):291-301. PubMed ID: 27715439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-Dependent Radiographic Vasospasm and Delayed Cerebral Ischemia in Women After Aneurysmal Subarachnoid Hemorrhage.
    Lai PMR; Gormley WB; Patel N; Frerichs KU; Aziz-Sultan MA; Du R
    World Neurosurg; 2019 Oct; 130():e230-e235. PubMed ID: 31203057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.